Monday, September 12, 2016

BRIEF-Contravir Pharmaceuticals reports new CRV431 data

* Reports new CRV431 data highlighting synergistic activity

with CMX157 against hepatitis B

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)